KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nov (NOV) EBITDA (2016 - 2026)

Nov's EBITDA history spans 18 years, with the latest figure at $47.0 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 69.08% to $47.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $389.0 million, a 55.08% decrease, with the full-year FY2025 number at $494.0 million, down 43.61% from a year prior.
  • EBITDA hit $47.0 million in Q1 2026 for Nov, down from $92.0 million in the prior quarter.
  • Over the last five years, EBITDA for NOV hit a ceiling of $313.0 million in Q2 2024 and a floor of -$361.0 million in Q4 2023.
  • Historically, EBITDA has averaged $106.5 million across 5 years, with a median of $143.0 million in 2025.
  • Biggest five-year swings in EBITDA: skyrocketed 1180.0% in 2022 and later plummeted 322.84% in 2023.
  • Tracing NOV's EBITDA over 5 years: stood at $162.0 million in 2022, then plummeted by 322.84% to -$361.0 million in 2023, then surged by 157.34% to $207.0 million in 2024, then plummeted by 55.56% to $92.0 million in 2025, then tumbled by 48.91% to $47.0 million in 2026.
  • Business Quant data shows EBITDA for NOV at $47.0 million in Q1 2026, $92.0 million in Q4 2025, and $107.0 million in Q3 2025.